After China announced 20 measures to optimize the prevention and control of the epidemic, the local and cities in many regions and cities will announce the cancellation or not for the time beingExpand the entire area of nucleic acid testing, including Zhenping County, Shaanxi Province, Fuzhou City, Fujian Province, Hefei City, Anhui Province, and Shanghai.Not China official last Friday (November 11) released 20 measures to further optimize the prevention and control of the epidemic. It is announced that the area where there is no crown disease must conduct nucleic acid tests on risk positions and key personnel in the scope, butThe scope of detection of nucleic acid is not allowed.NotAt the same time, the detection of all -staff nucleic acid tests can only be expanded only if the outbreak of the infected source and the dissemination chain is unclear, or the community has a long period of dissemination.Not The above measures were announced, China has adjusted epidemic prevention measures in many places.According to incomplete statistics from the First Financial Economics, Zhenping County, Shaanxi Province, Fuzhou City, Fujian Province, Guangchang County, Jiangxi Province, Yanji City, Jilin Province, Hefei City, Anhui Province, and Shanghai have adjusted the current epidemic prevention policy and announced the cancellation of the cancellationOr for the time being, the nucleic acid testing of the area will not be carried out for the time being.Not According to reports, Sanya City, Hainan Province, is one of the earliest regions in China to adjust epidemic prevention policies.Not In the case of China's adjustment of epidemic prevention control measures, the new cases of new single -day crown diseases in the fourth consecutive day are more than 10,000 cases. Guangdong, Henan, Chongqing, Beijing, Inner Mongolia and other places are more serious.Not According to the website of the National Health and Health Commission of China, 1,747 cases were diagnosed on Sunday (13th) in mainland China, and 14,325 cases of natives were asymptomatic.